Presentation Of Capabilities Elf


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Presentation Of Capabilities Elf

  1. 1. Presentation of Capabilities
  2. 2. Capabilities <ul><li>Penn Pharma’s Core Competencies include: </li></ul><ul><ul><li>Formulation Development </li></ul></ul><ul><ul><li>Analytical Services </li></ul></ul><ul><ul><li>Clinical Trial Supply </li></ul></ul><ul><ul><li>Commercial Manufacturing </li></ul></ul><ul><ul><li>Packaging & Labeling </li></ul></ul><ul><ul><li>Logistics </li></ul></ul><ul><ul><li>Contract Manufacture and Packaging </li></ul></ul><ul><ul><li>CMC and QP Consulting </li></ul></ul>
  3. 3. Capabilities <ul><li>Formulate, test & manufacture pharmaceutical products for clinical or commercial use </li></ul><ul><ul><li>Tablets </li></ul></ul><ul><ul><li>Capsules </li></ul></ul><ul><ul><li>Liquids </li></ul></ul><ul><ul><li>Ointments/creams </li></ul></ul><ul><ul><li>Suppositories </li></ul></ul><ul><ul><li>Granules </li></ul></ul><ul><li>Pack, store & distribute ALL forms of pharmaceutical products for clinical and commercial use </li></ul><ul><li>Import & release pharmaceutical products into the EU </li></ul>
  4. 4. Bldg 23 Bldg 24 ‘ Border’ Facilities Penn operates from a primary site of three hectares (323,000sq.ft.) in Tredegar and a new (75,000sq.ft.) storage facility in Oakdale, South Wales. (2.5 hours west of London)
  5. 5. Custom Manufacture and Packing <ul><ul><li>16 class 100,000 GMP rooms </li></ul></ul><ul><ul><li>Low humidity suites </li></ul></ul><ul><ul><li>One pot processing for blending, granulating and drying </li></ul></ul><ul><ul><li>Packing facilities </li></ul></ul>
  6. 6. Contained Manufacture Dedicated Containment Facility (DCF) <ul><ul><li>Fully contained Suite </li></ul></ul><ul><ul><ul><li>Handling of teratogenic compounds </li></ul></ul></ul>
  7. 7. Contained Manufacture Small Scale HCO Operations <ul><li>Operation </li></ul><ul><ul><li>Since January 2008 </li></ul></ul><ul><li>Containment Room </li></ul><ul><ul><li>class 100,000 </li></ul></ul><ul><ul><li>negative pressure </li></ul></ul><ul><ul><li>double airlock </li></ul></ul><ul><ul><li>single-pass HVAC </li></ul></ul><ul><ul><li>safe-change EU 13 HEPA filters </li></ul></ul><ul><li>Validation </li></ul><ul><ul><li>airborne containment by Lactose handling trials </li></ul></ul><ul><li>Standards </li></ul><ul><ul><li>conforms to ISO Class 8 (100,000); BS EN ISO 14644-1 (1999) & EU GMP volume IV </li></ul></ul>
  8. 8. <ul><li>Closed manufacturing system </li></ul><ul><ul><li>Isolator stage for dispensing highly potent API </li></ul></ul><ul><ul><li>ChargePoint valves for contained transfer of API (powder or solution) to a Zanchetta P10 one-pot high-shear mixer/granulator/dryer, or dry blender. </li></ul></ul><ul><ul><li>Contained transfers to milling & final blending stages </li></ul></ul><ul><ul><li>Contained transfer to tablet press, or capsule filler </li></ul></ul><ul><ul><li>Batch sizes currently ~ 3.5kg (wet) or 6.0kg (dry) </li></ul></ul><ul><ul><li>Process validated to OEL >1<10mcg/m3, OEB 4 (occupational exposure band) </li></ul></ul><ul><ul><li>In addition operators can wear positive pressure air suits (if necessary according to risk assessment) </li></ul></ul>Contained Manufacture Small Scale HCO Operations
  9. 9. <ul><li>We offer a complete range of Formulation Development Services including: • Pre-formulation studies. • Formulation of a wide variety of dosage forms. • Formulation and manufacture of batches for stability testing. • Scale up and production of pilot batches. • Formulation of clinical trials supplies from Phase l through to Phase lV. • Process validation and technology transfer. </li></ul><ul><li>The dosage forms on which we work include: • Solid Dose: Tablets, hard gelatin capsules, granules and powders. • Liquids: Oral and topical liquids, suspensions and emulsions. • Semi-solids: Creams, ointments and gels. • Parenterals </li></ul><ul><li>The types of dosage form technologies that we are familiar with include:- • Immediate release matrices • Sustained and controlled release formats. • Hot melt filling of capsules. • Film coating (particles and tablets). • Melt granulation </li></ul>Formulation Development
  10. 10. <ul><li>We have particular specialist expertise in formulating for poorly water soluble drugs using a range of non-proprietary solubility enhancement techniques. </li></ul><ul><li>Advances in combinatorial chemistry and high throughput screening techniques are producing more drug candidates with greater specificity towards biological targets. However, a great many of the compounds now coming through the development pipelines are Class II drugs according to the BCS classification, which means they exhibit good permeability through biological membranes, are lipophilic and, hence, poorly water soluble. </li></ul><ul><li>There are often problems associated with oral administration of this category of drug due to the limited solubility in the aqueous environment within the gastrointestinal tract. </li></ul><ul><li>The prime objective for Penn’s formulation scientists is to improve the water solubility of these drugs for our clients. </li></ul>
  11. 11. Analytical Services <ul><li>35 Station Lab </li></ul><ul><ul><li>32 HPLC’s </li></ul></ul><ul><ul><ul><li>1 UPLC with UV, RI, EC & ELSD detection </li></ul></ul></ul><ul><ul><li>2 GC headspace systems </li></ul></ul><ul><ul><li>Waters LCMS </li></ul></ul><ul><ul><li>2 containment labs (teratogenic/cytotoxic) </li></ul></ul><ul><ul><li>Dark room facility </li></ul></ul><ul><ul><li>Full dissolution capabilities </li></ul></ul><ul><ul><li>Full range of ICH stability storage including photo-stability </li></ul></ul><ul><li>Stability Volumes </li></ul><ul><ul><li>ICH light cabinet (refrigerated), 0.2m3 </li></ul></ul><ul><ul><li>2-8°c, 3.3m3 </li></ul></ul><ul><ul><li>25/60, 18m3 </li></ul></ul><ul><ul><li>30/60, 1.2m3 </li></ul></ul><ul><ul><li>30/65, 2.4m3 </li></ul></ul><ul><ul><li>40/75, 2.0m3 </li></ul></ul>
  12. 12. Clinical Trial Manufacture <ul><ul><li>Part of Penn’s Formulation Development Team </li></ul></ul><ul><ul><li>Scalability </li></ul></ul><ul><ul><ul><li>Direct scalability for one pot processing from 300g batch size to >300kg scale </li></ul></ul></ul><ul><ul><ul><li>Mi-Pro mini scale equipment allows early process development using gram quantities of API </li></ul></ul></ul><ul><ul><li>Capabilities same as Contract Manufacture </li></ul></ul>
  13. 13. Clinical Trial Supplies <ul><li>Packaging & Labelling </li></ul><ul><li>Investigational Initiated Studies </li></ul><ul><li>Commercial Product Sourcing for Clinical Trials </li></ul><ul><li>FastTrack CTS </li></ul>
  14. 14. <ul><li>Dedicated team for early phase and Phase I clinical trial projects </li></ul><ul><li>Seamless, integrated approach in line with Penn's other services </li></ul><ul><li>Each team member is experienced in protocol interpretation to the dispatch of supplies to investigator site </li></ul><ul><li>No transfer project between departments or groups which reduces miscommunication and loss of valuable time. </li></ul><ul><li>Simplicity of documentation reduces the amount of paperwork created but procedures still remains regulatory compliant </li></ul><ul><li>Many projects are completed within a 3 week period or less </li></ul>
  15. 15. Product Sourcing for CTS <ul><ul><li>Comparators </li></ul></ul><ul><ul><li>Rescue Medications </li></ul></ul><ul><ul><li>Non-Investigational Medicinal Products </li></ul></ul><ul><ul><li>Investigational Medicinal Product </li></ul></ul><ul><li>Penn sources from the most appropriate source and ensures QP input, assuring supply chain integrity. </li></ul>Understanding the difference between these categories and ensuring supply chain integrity is critical for any clinical trial. Many “comparator sourcing” companies do not understand the importance of these issues.
  16. 16. Logistics <ul><li>Temperature Controlled Warehousing </li></ul><ul><ul><li>Ambient </li></ul></ul><ul><ul><ul><li>2,650 pallet locations </li></ul></ul></ul><ul><ul><li>Refrigerated </li></ul></ul><ul><ul><ul><li>200m3 </li></ul></ul></ul><ul><ul><li>Frozen (-20°c) </li></ul></ul><ul><ul><ul><li>32m3 </li></ul></ul></ul><ul><ul><li>Controlled drugs </li></ul></ul><ul><ul><ul><li>22m3 </li></ul></ul></ul><ul><ul><li>Serge demand secure @ </li></ul></ul><ul><ul><ul><li>Movianto, Bedford, UK </li></ul></ul></ul><ul><ul><ul><ul><li>2-8°c, -20°c, Ambient & CD </li></ul></ul></ul></ul><ul><ul><ul><li>Biotec, Wales </li></ul></ul></ul><ul><ul><ul><ul><li>-20°c & -80°c </li></ul></ul></ul></ul>
  17. 17. QP Services / Consulting <ul><ul><li>Five-strong team of QPs </li></ul></ul><ul><ul><li>Diverse experience covering all dosage forms </li></ul></ul><ul><ul><li>Certify both IMP and licensed products </li></ul></ul><ul><ul><li>Undertake familiarisation audits of non-EU facilities </li></ul></ul><ul><ul><li>Large portfolio of audited manufacturing sites </li></ul></ul><ul><ul><li>Support EU Pharmaceutical Portal Service </li></ul></ul><ul><ul><li>Advise on all aspects of CMC </li></ul></ul><ul><ul><ul><li>API to commercial products </li></ul></ul></ul><ul><ul><li>IMPD Review and Advice </li></ul></ul><ul><ul><li>Online CMC consultancy service </li></ul></ul><ul><ul><li>Hosting various regulatory authority inspections </li></ul></ul><ul><ul><ul><li>MHRA, FDA, ANVISA </li></ul></ul></ul>
  18. 18. Why Penn Pharma? <ul><li>Penn Pharma provides an unparalleled suite of pharmaceutical development, clinical trial supply and manufacturing capabilities. Our flexible and personal approach ensures our clients are listened to and we offer cost effective and time saving solutions. Due to the volume and varied nature of the projects and the wide variety of clients we work with, our depth of knowledge and breadth of experience is unmatched. </li></ul><ul><li>Penn Pharma provides a suite of drug development, clinical trial supply, manufacturing and consultancy services. Our core services include formulation development, analytical development, clinical trial manufacture, packing, labeling, storage and distribution, returns reconciliation and destruction, custom manufacture, specials manufacture, hi-potency capabilities and CMC and QP release consultancy services. </li></ul>
  19. 19. Contact Us <ul><li>Head Office: Penn Pharma, 23-24 Tafarnaubach Industrial Estate, Tredegar, Gwent, NP22 3AA, UK Main Telephone: +44 (0) 1495 711 222 </li></ul><ul><li>Michael Kruidenier, Business Development Manager Tel: +44 (0) 1495 713 650 Mobile: +44 (0) 7791 751302 Email: [email_address] </li></ul>